Cardiac Surgery in Patients with End-Stage Renal Disease

Zamora, José; Burdine, James T.; Karlberg, Helena; Shenaq, Salwa M.; Noon, George P.

doi:10.1016/s0003-4975(10)61860-7

Cited by 64 publications

(21 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, Opsahl et al [28] reported a 2-year survival of 91.7% following CABG in 39 patients receiving maintenance HD. Several studies have also reported a symptomatic improvement and low operative mortality after CABG in end-stage renal disease [28][29][30]. However, in addition to the small number of patients in each study, no exact outcome has yet been reported regarding the effect of CABG on long-term survival in these patients [28,30].…”

Section: Discussionmentioning

confidence: 99%

Efficacy of Percutaneous Transluminal Coronary Angioplasty for Patients on Hemodialysis

et al. 1999

View full text Add to dashboard Cite

Ischemic heart disease has become more important in regard to mortality in hemodialysis (HD) patients. We examined the therapeutic outcome of initial percutaneous transluminal angioplasty (PTCA) in maintenance HD patients with angina pectoris. They consisted of 8 men and 4 women with a mean age of 56.3 ± 8.6 years and a mean duration of HD of 4.3 ± 4.0 years. Thirty-six non-HD patients treated with initial PTCA were matched for age, sex and coronary risk factors, and used as a control. Angiographic lesion success was confirmed by angiography in 21 (84%) of the 25 stenotic sites attempted and clinical success was obtained in 9 (75%) of the 12 HD patients, while there were 40 (78%) lesions successfully removed out of the 51 stenotic sites and there were 26 (72%) clinically successful cases out of the 36 non-HD patients, respectively. Angina recurred in 4 (44%) of 9 HD patients, and in 10 (38%) of 26 non-HD patients after successful PTCA, where the follow-up periods were 23 ± 20 and 28 ± 25 months, respectively. There was no significant difference in cumulative lesion survival curve between the two groups. In conclusion, PTCA for chronic HD patients is as effective as that for non-HD patients, at least regarding initial PTCA.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy of Percutaneous Transluminal Coronary Angioplasty for Patients on Hemodialysis

et al. 1999

View full text Add to dashboard Cite

show abstract

“…Some investigators have shown improvement in late cardiac symptoms after coronary bypass in dialysis patients 89 11 12 However, the long term benefit and the impact of coronary artery bypass graft surgery on survival in this group of patients is controversial (table 1). In a study by Opsahl et al ,8 the survival in patients who underwent coronary revascularisation was better than in those who were treated medically, but this difference was not significant.…”

Section: Discussionmentioning

confidence: 99%

Coronary artery bypass graft surgery in dialysis patients

Jahangiri

Wright

Edmondson

et al. 1997

Heart

View full text Add to dashboard Cite

Objective-To examine the short term results and long term survival of patients on long term dialysis undergoing coronary artery bypass graft surgery. Methods-A retrospective analysis of 19 patients on established dialysis who underwent coronary revascularisation between 1983 and 1995; 14 patients (73%) had class IV angina and five (25%) had unstable angina requiring heparin and nitrate infusions before surgery. Results-The 30 day mortality was 5%. Follow up was completed in the remaining 18 patients. The mean follow up time was 34 months (range eight to 61). During the follow up period four patients died of cardiac causes. The actuarial survival at one, two, and three years was 87%, 78%, and 59%, respectively. The overall functional status was significantly improved compared to preoperative levels, with a mean Karnofsky score of 76% (p < 0.01) at three years. Conclusions-Coronary artery bypass graft surgery can be performed with increased but acceptable morbidity and mortality in chronic dialysis patients. It results in considerable improvement in symptoms and functional status. However, long term survival is limited and this requires further investigation.

show abstract

“…The procedural mortality rate of CABG in chronic hemodialysis patients was found to be similar to the patients with normal renal function in the studies of Zamora et al [9] and Batiuk et al [10]. In contrast, surgical team from the University of Louvain Medical School, Brussels, Belgium, reported that the in-hospital mortality (11%) of the chronic hemodialysis patients undergoing CABG was significantly higher than the nonuremic patients (2.6%) [11,12].…”

Section: Discussionmentioning

confidence: 86%

Short- and long-term outcomes after percutaneous transluminal coronary angioplasty in chronic hemodialysis patients

Hang

Chen

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

The aim of this study was to obtain data on the outcomes of chronic hemodialysis patients who underwent percutaneous transluminal coronary angioplasty (PTCA). A retrospective chart analysis identified 31 such patients between August 1992 and October 1996. The mean follow‐up period was 12.4 ± 11.7 months. Angiographic success was achieved in 39 of 41 (95.1%) stenoses attempted. There were three in‐hospital deaths. Clinical success was achieved in 28 of 31 patients (90%). Two of the 28 survivors were lost to follow‐up. Recurrent angina developed within 6 months in 14 of 26 patients (53.8%). Eleven and 17 of the 26 patients (42.3% and 65.4%) died within 6 and 14 months, respectively, after the PTCA procedure. Ten of the 17 deaths (58.8%) were due to cardiovascular events. Our study suggests that PTCA is technically feasible with high angiographic success rate in chronic hemodialysis patients. In‐hospital mortality rate and rate of recurrent angina are high. Long‐term prognosis is poor. Cathet. Cardiovasc. Intervent. 47:430–433, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Cardiac Surgery in Patients with End-Stage Renal Disease

Cited by 64 publications

References 36 publications

Efficacy of Percutaneous Transluminal Coronary Angioplasty for Patients on Hemodialysis

Efficacy of Percutaneous Transluminal Coronary Angioplasty for Patients on Hemodialysis

Coronary artery bypass graft surgery in dialysis patients

Short- and long-term outcomes after percutaneous transluminal coronary angioplasty in chronic hemodialysis patients

Contact Info

Product

Resources

About